Race Oncology Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Net Income	-4.79	-13.82	-9.92	-11.2	-6.34	Upgrade
Depreciation & Amortization	0.28	0.28	0.28	0.28	0.28	Upgrade
Stock-Based Compensation	1.42	1.43	0.59	3.07	2.28	Upgrade
Other Operating Activities	0.01	-	0.08	0.04	-0.01	Upgrade
Change in Accounts Receivable	0.08	1.6	-1.64	0.07	-0.08	Upgrade
Change in Accounts Payable	-0.46	0.68	-0.27	0.89	0.28	Upgrade
Change in Other Net Operating Assets	-1.12	0.28	0.23	0.59	-1.11	Upgrade
Operating Cash Flow	-4.57	-9.55	-10.65	-6.26	-4.7	Upgrade
Issuance of Common Stock	1.06	5.21	-	30.98	12.79	Upgrade
Other Financing Activities	-	-0	-1.28	-0.46	-0.51	Upgrade
Financing Cash Flow	1.06	5.21	-1.28	30.51	12.28	Upgrade
Foreign Exchange Rate Adjustments	-0.01	0.01	-0.09	-0.04	0.01	Upgrade
Net Cash Flow	-3.52	-4.33	-12.02	24.22	7.59	Upgrade
Cash Income Tax Paid	-	-	-	-	-0.39	Upgrade
Levered Free Cash Flow	-2.72	-4.31	-7.36	-2.1	-2.14	Upgrade
Unlevered Free Cash Flow	-2.72	-4.31	-7.36	-2.1	-2.14	Upgrade
Change in Working Capital	-1.5	2.56	-1.68	1.55	-0.91	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.